Nuclear Radiology: Page 70

IBA, Wilex meet FDA on Redectane trial
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) and drug company Wilex recently met with the U.S. Food and Drug Administration to discuss the regulatory review process for IBA's Redectane PET/CT radiopharmaceutical.
June 19, 2011
Don't write off nuclear cardiology, urges U.K. specialist
By Edna Astbury-Ward, PhD
The stunning success of cardiac CT perfusion has led some experts to question whether nuclear cardiology has a future, but it may be premature to write off nuclear cardiology. It is a robust, tried, and tested field supported by very established data, according to a U.K. specialist.
June 7, 2011
2011 06 08 08 40 52 250 2011 06 08 Nuclear Thumb
SNM: Hybrid PET/MRI study among top 5 research papers
By Wayne Forrest
SAN ANTONIO - The first-ever study on the clinical use of PET/MRI and a breakthrough on the use of FDG-PET to detect fevers of unknown origin were among the top research papers outlined Monday at this week's Society of Nuclear Medicine (SNM) annual meeting.
June 7, 2011
2011 06 07 09 54 33 43 Fever Unknown Origin Thumb
GE signs PET agent R&D deal with ImaginAb
By AuntMinnieEurope.com staff writers
GE Healthcare has signed an R&D deal with ImaginAb to develop new PET radiopharmaceuticals based on ImaginAb's antibody fragment technology.
June 6, 2011
PET scanner shows early breast cancer
By AuntMinnieEurope.com staff writers
European researchers say they have developed a clinical PET system with enhanced resolution and the sensitivity to detect breast cancer in its early stages.
May 19, 2011
PET enables better monitoring of intratumoral changes
By Becky McCall
Growing use of hypofractionation in clinical practice and its link to increased treatment resistance due to tumor cell hypoxia means that it may be beneficial to visualize and quantify hypoxic areas with PET imaging to monitor changes in tumor metabolism during treatment.
May 18, 2011
2011 05 19 11 21 20 441 Bussink Thumb
IsoRay nets revenue gain in Q3
By AuntMinnieEurope.com staff writers
A 21% increase in patient cases helped medical isotope developer IsoRay Medical to a third-quarter revenue gain and a lower net loss compared to the same quarter of the prior year.
May 16, 2011
GE to sell MPI stress agent in Europe
By AuntMinnieEurope.com staff writers
GE Healthcare has signed an agreement with Rapidscan Pharma Solutions to sell that company's pharmacological stress agent for myocardial perfusion imaging (MPI) studies in Europe.
May 15, 2011
PET/CT changes status in more than a third of cases
By Rebekah Moan
When the capacity of PET/CT is unlimited, using the modality causes a change in diagnosis, staging, or treatment plan in more than a third of cancer patients, Danish researchers note in the June print edition of European Radiology.
May 12, 2011
IBA revenues increase by 20% in Q1
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) reported nearly 20% revenue growth in its first quarter.
May 11, 2011
PET/CT helps target radiation therapy of NSCLC tumors
By Becky McCall
LONDON - PET/CT prior to radiotherapy can help oncologists target a more powerful dose of radiation to non-small cell lung cancer (NSCLC), whilst keeping dose low in other areas of the organ, according to research presented at this week's European Society for Therapeutic Radiology and Oncology meeting.
May 10, 2011
2011 05 11 14 00 56 747 Estro Clinical 394
Eckert & Ziegler grows Q1 revenues
By AuntMinnieEurope.com staff writers
Earnings from its isotope products segment powered Eckert & Ziegler, parent company of radiotherapy and radioisotope developer Eckert & Ziegler Isotope Products, to a prosperous first quarter.
May 2, 2011
Previous Page
Page 70 of 90
Next Page